AU2005282182A1 - Human milk fortifiers and methods for their production - Google Patents

Human milk fortifiers and methods for their production Download PDF

Info

Publication number
AU2005282182A1
AU2005282182A1 AU2005282182A AU2005282182A AU2005282182A1 AU 2005282182 A1 AU2005282182 A1 AU 2005282182A1 AU 2005282182 A AU2005282182 A AU 2005282182A AU 2005282182 A AU2005282182 A AU 2005282182A AU 2005282182 A1 AU2005282182 A1 AU 2005282182A1
Authority
AU
Australia
Prior art keywords
milk
fortifier
human
fortified
component
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Abandoned
Application number
AU2005282182A
Other languages
English (en)
Inventor
Bronwyn Estelle Davis
Peter Edwin Hartmann
Ching Tat Lai
Michelle Anne Lewis
Leon Robert Mitoulas
Jillian Lois Sherriff
Karen Norrie Simmer
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Medela Holding AG
Original Assignee
Medela Holding AG
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from EP04405592A external-priority patent/EP1637043A1/en
Application filed by Medela Holding AG filed Critical Medela Holding AG
Publication of AU2005282182A1 publication Critical patent/AU2005282182A1/en
Abandoned legal-status Critical Current

Links

Classifications

    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61KPREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
    • A61K35/00Medicinal preparations containing materials or reaction products thereof with undetermined constitution
    • A61K35/12Materials from mammals; Compositions comprising non-specified tissues or cells; Compositions comprising non-embryonic stem cells; Genetically modified cells
    • A61K35/20Milk; Whey; Colostrum
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23CDAIRY PRODUCTS, e.g. MILK, BUTTER OR CHEESE; MILK OR CHEESE SUBSTITUTES; PREPARATION THEREOF
    • A23C9/00Milk preparations; Milk powder or milk powder preparations
    • A23C9/20Dietetic milk products not covered by groups A23C9/12 - A23C9/18
    • A23C9/206Colostrum; Human milk
    • AHUMAN NECESSITIES
    • A23FOODS OR FOODSTUFFS; TREATMENT THEREOF, NOT COVERED BY OTHER CLASSES
    • A23LFOODS, FOODSTUFFS OR NON-ALCOHOLIC BEVERAGES, NOT OTHERWISE PROVIDED FOR; PREPARATION OR TREATMENT THEREOF
    • A23L33/00Modifying nutritive qualities of foods; Dietetic products; Preparation or treatment thereof
    • A23L33/40Complete food formulations for specific consumer groups or specific purposes, e.g. infant formula
    • AHUMAN NECESSITIES
    • A61MEDICAL OR VETERINARY SCIENCE; HYGIENE
    • A61PSPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
    • A61P3/00Drugs for disorders of the metabolism
    • A61P3/02Nutrients, e.g. vitamins, minerals

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Chemical & Material Sciences (AREA)
  • Nutrition Science (AREA)
  • Polymers & Plastics (AREA)
  • Food Science & Technology (AREA)
  • Veterinary Medicine (AREA)
  • Public Health (AREA)
  • General Health & Medical Sciences (AREA)
  • Animal Behavior & Ethology (AREA)
  • Medicinal Chemistry (AREA)
  • Pharmacology & Pharmacy (AREA)
  • Virology (AREA)
  • Epidemiology (AREA)
  • Zoology (AREA)
  • Immunology (AREA)
  • Developmental Biology & Embryology (AREA)
  • Pediatric Medicine (AREA)
  • Mycology (AREA)
  • Cell Biology (AREA)
  • Biotechnology (AREA)
  • Biomedical Technology (AREA)
  • Diabetes (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Hematology (AREA)
  • Obesity (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • General Chemical & Material Sciences (AREA)
  • Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
  • Organic Chemistry (AREA)
  • Medicines Containing Material From Animals Or Micro-Organisms (AREA)
  • Dairy Products (AREA)
  • Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
AU2005282182A 2004-09-10 2005-09-02 Human milk fortifiers and methods for their production Abandoned AU2005282182A1 (en)

Applications Claiming Priority (5)

Application Number Priority Date Filing Date Title
EP04405567 2004-09-10
EP04405567.1 2004-09-10
EP04405592.9 2004-09-17
EP04405592A EP1637043A1 (en) 2004-09-17 2004-09-17 Human milk fortifiers and methods for their production
PCT/CH2005/000518 WO2006026878A1 (en) 2004-09-10 2005-09-02 Human milk fortifiers and methods for their production

Publications (1)

Publication Number Publication Date
AU2005282182A1 true AU2005282182A1 (en) 2006-03-16

Family

ID=35511068

Family Applications (1)

Application Number Title Priority Date Filing Date
AU2005282182A Abandoned AU2005282182A1 (en) 2004-09-10 2005-09-02 Human milk fortifiers and methods for their production

Country Status (5)

Country Link
US (1) US20080187619A1 (https=)
EP (1) EP1791444A1 (https=)
JP (1) JP2008512398A (https=)
AU (1) AU2005282182A1 (https=)
WO (1) WO2006026878A1 (https=)

Families Citing this family (27)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US20020182243A1 (en) * 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
US20100268658A1 (en) * 2001-05-14 2010-10-21 Prolacta Bioscience Method for collecting, testing and distributing milk
EP1787114A1 (en) * 2004-09-10 2007-05-23 Medela Holding AG Method for analysing and treating human milk and system therefore
WO2007035870A2 (en) 2005-09-20 2007-03-29 Prolacta Bioscience, Inc. A method for testing milk
MX2008013024A (es) * 2006-04-11 2009-04-16 Mileutis Ltd Manejo de ganado para la eficiencia reproductiva mejorada.
EP2063722B1 (en) * 2006-08-30 2017-05-03 Prolacta Bioscience, Inc. Methods of obtaining sterile milk and compositions thereof
CA2706722C (en) * 2006-11-29 2016-01-12 Prolacta Bioscience, Inc. Human milk compositions and methods of making and using same
US8377445B2 (en) * 2006-12-08 2013-02-19 Prolacta Bioscience, Inc. Compositions of human lipids and methods of making and using same
CN102300575A (zh) 2008-12-02 2011-12-28 普罗莱克塔生物科学公司 人乳渗透物组合物及其制备和使用方法
EP2248908A1 (en) * 2009-05-05 2010-11-10 Eurolactis Group S.A. Probiotic microorganisms isolated from donkey milk
CN103987265B (zh) 2011-08-03 2017-05-24 普罗莱克塔生物科学公司 减少细菌污染的人乳微滤
FI3821713T3 (fi) 2013-03-13 2025-03-27 Prolacta Bioscience Inc Runsasrasvaisia äidinmaitotuotteita
US9661868B2 (en) * 2013-07-16 2017-05-30 Mead Johnson Nutrition Company Expanded bed adsorption methods for isolation of basic milk proteins including lactoferrin
ITMI20131690A1 (it) * 2013-10-14 2015-04-15 Consiglio Nazionale Ricerche Composizione alimentare.
US20150208681A1 (en) * 2014-01-03 2015-07-30 Elizabeth Rinaldi Schinkel Method and apparatus for fortifying breast milk
EP2957178A1 (en) * 2014-06-16 2015-12-23 Carag AG Method and apparatus for preparation of human milk to be stored
WO2016016796A1 (en) 2014-07-28 2016-02-04 Nestec S.A. Devices and kits for production of personalized, concentrated human milk compositions, and methods of making and using same
AU2016381834B2 (en) * 2015-12-30 2021-09-23 Prolacta Bioscience, Inc. Human milk products useful in pre- and post-operative care
US20230103295A1 (en) * 2016-12-25 2023-04-06 LactaLogics, Inc. Processing human milk for generating compositions of fortified human milk products
KR102004320B1 (ko) * 2017-09-20 2019-07-29 건국대학교 글로컬산학협력단 모유은행 기증모유의 동결건조보관 방법
US12070044B2 (en) 2019-02-22 2024-08-27 Aquero Canada Ltd. Fortified milk compositions and their processes of preparation
JP2022548785A (ja) 2019-09-24 2022-11-21 プロラクタ バイオサイエンス,インコーポレイテッド 炎症性疾患及び免疫疾患の治療のための組成物及び方法
WO2021219635A2 (en) * 2020-04-27 2021-11-04 Société des Produits Nestlé S.A. Method for producing milk like products
MX2022013442A (es) * 2020-04-27 2022-11-30 Nestle Sa Metodo para producir productos similares a la leche.
US11206843B1 (en) * 2020-05-26 2021-12-28 BIOMILQ, Inc. Milk product compositions
WO2022200526A1 (de) * 2021-03-24 2022-09-29 Ammeva Gmbh Getrocknete frauenmilch zum einsatz als nahrungsergänzungsmittel, lebensmittel für besondere medizinische zwecke und als alleinnahrungsmittel für säuglinge
WO2022213149A1 (en) * 2021-04-06 2022-10-13 John Kapeleris Infant formula

Family Cites Families (8)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US6020015A (en) * 1988-09-22 2000-02-01 Gaull; Gerald E. Infant formula compositions and nutrition containing genetically engineered human milk proteins
US5169666A (en) * 1991-11-14 1992-12-08 The United States Of America As Represented By The Secretary Of Agriculture Preparation of simulated human milk protein by low temperature microfiltration
US6162472A (en) * 1998-07-28 2000-12-19 University Of Virginia Patent Foundation Nutritional formula for premature infants and method of making
CA2260673A1 (en) * 1999-02-04 2000-08-04 Natrel Inc. A process for making a lactose-free milk without negatively affecting the organoleptic properties thereof; and milk so processed
US6294206B1 (en) * 1999-04-09 2001-09-25 Abbott Laboratories Powdered human milk fortifier
US20020182243A1 (en) 2001-05-14 2002-12-05 Medo Elena Maria Method of producing nutritional products from human milk tissue and compositions thereof
US6875459B2 (en) * 2001-09-10 2005-04-05 Henry B. Kopf Method and apparatus for separation of milk, colostrum, and whey
EP1787114A1 (en) * 2004-09-10 2007-05-23 Medela Holding AG Method for analysing and treating human milk and system therefore

Also Published As

Publication number Publication date
JP2008512398A (ja) 2008-04-24
WO2006026878A1 (en) 2006-03-16
US20080187619A1 (en) 2008-08-07
EP1791444A1 (en) 2007-06-06

Similar Documents

Publication Publication Date Title
US20080187619A1 (en) Human Milk Fortifiers and Methods for Their Production
JP7793573B2 (ja) 乳タンパク質および乳糖を含む改善された栄養製品の製造方法ならびにこの方法により得られた製品
EP1637043A1 (en) Human milk fortifiers and methods for their production
CA2706723C (en) Compositions of human lipids and methods of making and using same
Räihä Nutritional proteins in milk and the protein requirement of normal infants
EP3917338B1 (en) Native whey protein for improving intestinal maturation
EP3791726A1 (en) A dry powdered human milk fortifier
Crowley et al. Potential applications of non‐bovine mammalian milk in infant nutrition
EP3917547A1 (en) Native whey protein for treating and/or preventing intestinal infection
CN113660867B (zh) 在胃条件下显示相分离的营养组合物及其制备方法
Räihä Milk protein quantity and quality and protein requirements during development
CN101014253A (zh) 人乳强化剂及其生产方法
EP1637880A1 (en) Method for analysing and treating human milk and system therefor
EP4057841B1 (en) Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract
CN118265463A (zh) 含有血清蛋白浓缩物的婴儿配方乳粉
US20220079186A1 (en) Liquid composition comprised of a micellar casein concentrate
WO2022175218A1 (en) Milk with a high immunoglobulin content
Räihä Protein quantity and quality in infant feeding
WO2022078679A1 (en) Nutritional composition
HK40081708A (en) Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract
HK40081708B (en) Use of alpha-lactalbumin enriched whey protein extract as a source of cholesterol and synthetic nutritional composition comprising an alpha-lactalbumin enriched whey protein extract
Salle et al. IN FULL-TERM AND PREMATURE NEWBORNS

Legal Events

Date Code Title Description
MK4 Application lapsed section 142(2)(d) - no continuation fee paid for the application